# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Piper Sandler analyst Matt O'Brien reiterates Sight Sciences (NASDAQ:SGHT) with a Neutral and raises the price target fr...
Needham analyst David Saxon reiterates Sight Sciences (NASDAQ:SGHT) with a Hold.
Sight Sciences (NASDAQ:SGHT) reported quarterly losses of $(0.33) per share which missed the analyst consensus estimate of $(0....
Sight Sciences, Inc. (NASDAQ:SGHT) ("Sight Sciences" or the "Company"), an eyecare technology company focused o...
Needham analyst David Saxon reiterates Sight Sciences (NASDAQ:SGHT) with a Hold.